Dr Rachel Chikwamba holds the position of CSIR Group Executive for the Advanced Chemistry and Life Sciences division. In this role, she spearheads the implementation of the CSIR Strategy within the respective sectors. Dr Chikwamba collaborates closely with academia, as well as the public and private sector partners, both locally and internationally, to foster innovation that contributes to enhancing sectoral competitiveness and economic performance.
Dr Chikwamba has led a number of strategic initiatives for the CSIR. Most recently, she led the CSIR commercialisation initiative, culminating in the launch of CSIR C Cubed, a dedicated capability that brings together CSIR intellectual property (IP), entrepreneurs and financial resources to accelerate the pace at which CSIR IP is translated into products and services that enhance economic competitiveness of industry and enable a capable state. Prior to this initiative, Dr Chikwamba led Project Synapse, an initiative that defined a renewed vision and mission of the organisation, strategic objectives, the programmatic focus areas, operating and business models, as well as the strategy implementation plan. This process culminated in the current organisational strategy.
Dr Chikwamba formerly served as the Group Executive for Strategic Alliances and Communication. In this role, she led efforts to establish and foster organisational partnerships with local and global stakeholders in the public and private sectors. The primary objective was to leverage science, technology and innovation to advance knowledge and address challenges related to socioeconomic and industrial development.
Rachel has served and is serving on the boards of various organisations, focusing on agriculture and health. Notably, she has been a part of the Global Governing Board of ICRISAT, the Board of Directors of the Wits Health Consortium (Pty) Ltd and the South African Medical Research Council. In addition, she was recently appointed to the African Union (AU) Panel on Emerging Technologies. The panel is responsible for providing guidance to the AU and its member states regarding the effective utilisation of emerging technologies for economic development.
Dr Chikwamba holds a PhD in Genetics from Iowa State University in the United States of America (USA) and a Master of Business Administration from the Gordon Institute of Business Science at the University of Pretoria in South Africa. She is a member of the Academy of Science of South Africa and has also held an Honorary Research Fellowship at St. Georges Hospital Medical School, University of London. Rachel joined the CSIR in December 2004, following her role as a postdoctoral research associate at Arizona State University, USA.